The HIV part was when GTCB made goats to supply PRO542, an anti-HIV protein, to PGNX. Since then PGNX has shelved, but not killed PRO542. They are moving forward with PRO140, a monoclonal anti-body that shows significianclty better efficacy. The phase II data for PRO140 should by the end of 2008.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.